Application for Monitoring & Evaluation of Raynaud's Phenomenon

Updated 05/03/2024

Status Recruiting

Clinical Trial Summary

To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03984422
Study type	Observational
Source	University Hospital, Grenoble
Contact	Matthieu Roustit, PharmD, PhD
Phone	+33476767856
Email	mroustit@chu-grenoble.fr
Status	Recruiting
Phase
Start date	March 31, 2020
Completion date	June 30, 2024

See also
	Status	Clinical Trial	Phase
	Withdrawn	`NCT03393325` - Tadalafil-Delivra and Raynaud's Phenomenon
	Recruiting	`NCT03749577` - Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon	N/A
	Completed	`NCT03699436` - Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon	N/A
	Enrolling by invitation	`NCT06291142` - Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
	Recruiting	`NCT04015193` - Follow-up of SPTS in Patients With Raynaud's Phenomenon
	Not yet recruiting	`NCT03972566` - Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
	Completed	`NCT04854850` - Apollo Device for Fatigue in Systemic Sclerosis	N/A
	Completed	`NCT03129178` - Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon	N/A
	Completed	`NCT04388176` - Cold Challenge With C21 in RP	Phase 2
	Completed	`NCT01280266` - Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon	Phase 2/Phase 3
	Completed	`NCT04644523` - Dermoscopy in Primary Raynaud's Phenomenon
	Completed	`NCT03094910` - Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon	N/A
	Recruiting	`NCT05204784` - Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis	N/A
	Recruiting	`NCT05125029` - Botulinum Toxin in Raynaud's Phenomenon	Phase 4
	Terminated	`NCT03639766` - The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon	Phase 4
	Withdrawn	`NCT04898036` - Phototherapy For Treatment Of Raynaud's Phenomenon	N/A
	Terminated	`NCT03869008` - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.	N/A
	Recruiting	`NCT01347008` - Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis	Phase 3